Evidence map›Paper›PMID 42212389›Full record

ArticleOncology reports2026

[Corrigendum] 17‑AAG synergizes with Belinostat to exhibit a negative effect on the proliferation and invasion of MDA‑MB‑231 breast cancer cells.

Yu Zuo, Heng Xu, Zhifeng Chen, Fengmin Xiong, Bei Zhang, Kaixian Chen, Hualiang Jiang, Cheng Luo, Hao Zhang

Abstract readPublished Erratum
In one paragraph

Article in Oncology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Yu ZuoDepartment of Pharmacy, School of Pharmacy, Nanchang University, Nanchang, Jiangxi 330006, P.R. China.
Heng XuDepartment of Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, P.R. China.
Zhifeng ChenDepartment of Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, P.R. China.
Fengmin XiongDepartment of Pharmacy, School of Pharmacy, Nanchang University, Nanchang, Jiangxi 330006, P.R. China.
Bei ZhangDepartment of Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, P.R. China.
Kaixian ChenDepartment of Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, P.R. China.
Hualiang JiangDepartment of Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, P.R. China.
Cheng LuoDepartment of Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, P.R. China.
Hao ZhangDepartment of Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Subsequently to the publication of the above paper, an interested reader drew to the authors' attention that, concerning the Transwell migration assay experiments shown in Fig. 6F on p. 1940, the 'NC' and 'siTEAD3' experiments showed an overlapping section of data, such that data which were intended to show the results from differently performed experiments had apparently been derived from the same original source. The authors proposed removing Fig. 6F from the figure, as they considered that the conclusions of these experiments were sufficiently well supported by the data shown in Fig. 6D and E, although the Editor expressed to them our preference that the authors should repeat these experiments, if necessary, to rectify the original errors made during the inaccurate assembly of data in Fig. 6F. The authors were willing to perform the requested experiments, and the revised version of Fig. 6, showing the replacement data for the migration assay experiments in Fig. 6F, is shown on the next page. The authors wish to draw the readers' attention to the fact that the statistical significance of the experiments featured in the new Fig. 6F was not exactly the same as that in the original figure (note the change to the wording of the figure legend opposite, which is highlighted in bold); however, the conclusion that knocking out TEAD family proteins significantly inhibits the migration of MDA-MB-231 cells is completely consistent with the conclusion of the original article. This difference in the statistical significance of the results is reflected in a proposed change of the wording to describe the results of Fig. 6F in the manuscript; therefore, the final sentence of the Results section, left-hand column on p. 1941, should now read as follows: 'As shown in the results of the cell migration assay (Fig. 6F),

Indexed as

heat shock protein 90 inhibitorhistone deacetylase 6 inhibitorsynergistictriple‑negative breast cancer

Identifiers

PMID42212389
PMCPMC13247675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.